Broome Oncology

Gastric Cancer News

Immunotherapy comparable to chemo for some advanced stomach cancers (June 4, 2019)

An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe. For some, the immune-boosting treatment offered improved survival compared to standard treatment. The... Continue Reading

FDA Approves Lonsurf® for Treatment of Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (March 8, 2019)

The United States Food and Drug Administration (FDA) has approved Lonsurf® (trifluridine/tipiracil)) as a treatment for adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines... Continue Reading

Diagnosed with Gastric Cancer: 10 Tips on How to Get The Most From Your Doctor (December 21, 2017)

1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with gastric cancer and often work in collaboration. Pick your primary oncologist carefully, rely on people you trust including nurses... Continue Reading

New Standard of Care for Treatment of Resectable Gastric Cancer (October 3, 2017)

The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable... Continue Reading

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer (September 25, 2017)

Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this new indication must have PD-L1-expressing tumors,... Continue Reading

Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer (September 18, 2017)

Keytruda (pembrolizumab) appears promising in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid.1 Stomach... Continue Reading

Latest Gastric Cancer News By Stage


Recurrent Gastric Cancer

Sorry, there are no articles available for this cancer stage.

More Recurrent Gastric Cancer

Screening/Prevention Gastric Cancer

Sorry, there are no articles available for this cancer stage.

More Screening/Prevention Gastric Cancer

Stages I-II Gastric Cancer

Sorry, there are no articles available for this cancer stage.

More Stages I-II Gastric Cancer

Stages III-IV Gastric Cancer

Sorry, there are no articles available for this cancer stage.

More Stages III-IV Gastric Cancer